𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands

✍ Scribed by L. de Munck; M. Schaapveld; S. Siesling; J. Wesseling; A. C. Voogd; V. C. G. Tjan-Heijnen; R. Otter; P. H. B. Willemse

Publisher
Springer US
Year
2011
Tongue
English
Weight
192 KB
Volume
129
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of prior adjuvant chemotherap
The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer
✍ Frederick R. Ahmann; Stephen E. Jones; Thomas E. Moon πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 550 KB

Some adjuvantly treated patients develop recurrent breast cancer and little is known about the effect of prior adjuvant chemotherapy on subsequent response rates to systemic therapy or on overall survival. We describe our retrospective comparison of 179 patients who received doxorubicin containing a

Cost-effectiveness analysis of trastuzum
Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer
✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t